Roche launches new high throughput configurations for cobas pro integrated solutions to increase testing efficiency
This feature will allow a greater number of patient samples to be processed faster
This feature will allow a greater number of patient samples to be processed faster
Join us on Wednesday, December 2, to learn how the BioAccord LC-MS System delivers robust UPLC separations performance and accurate mass data for a diverse range of modified oligonucleotides
Join us on Tuesday, September 15, for part one of the Syft Webinar Series on selected ion flow tube mass spectrometry
Improve robustness and operability for high-speed, high-sensitivity analysis
The new product variant promises biodirectional measurement of flow rates up to ±3000 µl/min
Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.
Patient blood management experts share how nuanced approaches beyond following hemoglobin thresholds can help lead to better patient outcomes
Interoperable AI-powered digital pathology workflows support confident cancer diagnosis
Learn about the pioneering work of the Columbia Stem Cell Initiative and how technological advancements are helping drive scientific breakthroughs at its Flow Cytometry Core Facility
Sir Ranulph Fiennes attends launch event at the Source BioScience facility in Rochdale
Sangmi Han discusses how cell counters have become an integral part of Macrogen’s single-cell RNA sequencing workflow
Learn how the new real-time multi-angle light scattering (RT-MALS) technology continuously monitors and measures critical quality attributes during viral vector production
Explore the importance of the European Pharmacopoeia to pharma manufacturers worldwide, with exclusive insights into the recently released version
Tomás Palacios explores the application of novel materials in next-generation electronics to save energy and expand possibilities
Explore the importance of robust and reliable cell-based assays in the development of therapeutic bispecific antibodies in immuno-oncology